Interactive worksheet
Population Lp(a) Screening Benefit Estimator
This tool estimates the potential population-level yield and benefit of one-time Lp(a) screening. It uses inputs for population size, expected prevalence above a chosen threshold, baseline 10-year ASCVD risk, the relative risk associated with elevated Lp(a), and assumed therapy uptake and relative risk reduction. Notes: Prevalence of Lp(a) ≥125 nmol/L (≈50 mg/dL) is ~20% in many populations; adjust for your local epi